Micro Vision, Inc. Signs Patent License Agreement with Taiwanese ODM to make and sell LBS engines.
Nov 21, 2016,MicroVision, Inc. (hereinafter referred as “MVIS”),has announced that it has signed a license agreement for its PicoP® scanning technology with a Taiwanese ODM, under which the ODM has a license to make and sell Laser Beam Scanning (hereinafter referred as “LBS” ) engines.[1] The engines, ODM is manufacturing incorporate components it is purchasing from third […]
Allergan Plc: Continue to Strengthen Its Presence and Innovation in GI market
Reportedly, on Oct 3, 2016, Allegran Plc; headquartered in New Jersey (US) announced that it has entered into an exclusive worldwide licensing agreement with MedImmune (AstraZeneca’s R&D arm) to develop and commercialize MEDI2070 which finally get completed on Nov 17, 2016. As per the terms of the agreement, Allergan will pay an upfront payment to […]
Micro Vision, Inc. Signs Patent License Agreement with Taiwanese ODM to make and sell LBS engines.
Nov 21, 2016,MicroVision, Inc. (hereinafter referred as “MVIS”),has announced that it has signed a license agreement for its PicoP® scanning technology with a Taiwanese ODM, under which the ODM has a license to make and sell Laser Beam Scanning (hereinafter referred as “LBS” ) engines.[1] The engines, ODM is manufacturing incorporate components it is purchasing […]
Inside Secure states, France Brevets licenses NFC Patents to HTC
Access to robust data and effective analytics are the must for today’s business world. But sometimes it can be difficult to acquire good data. That’s where near-field communication (hereinafter referred as “NFC”) technology comes in. NFC is a short-range high-frequency wireless communication technology which enables the exchange of data between devices when they’re touched together […]
China (SIPO) Proposed Amendments Patent Examination Guidelines
On October 27, 2016, the Chinese Patent Office – State Intellectual Property Office (SIPO) published Revised Patent Examination Guidelines draft to remove the software and business method patents hurdles in Chinese Jurisdiction. The published draft will be open for public comments till November 27, 2016. Chinese Patent Law, under Article 25(2) mandates that patent rights […]
Inside Secure states, France Brevets licenses NFC Patents to HTC
Access to robust data and effective analytics are the must for today’s business world. But sometimes it can be difficult to acquire good data. That’s where near-field communication (hereinafter referred as “NFC”) technology comes in. NFC is a short-range high-frequency wireless communication technology which enables the exchange of data between devices when they’re touched together […]
RENOVA Expands Intellectual Property Portfolio For Cardiovascular And Metabolic Disease Treatments
Renova Therapeutics(hereinafter referred as “Renova”) founded in 2009 and headquartered in San Diego, California, a biopharmaceutical company develops gene therapy treatments for congestive heart failure (CHF) and other chronic diseases The Company also provides gene therapies in pre-clinical stage for those who suffer from Type II diabetes. Reportedly, Renova has obtained an exclusive worldwide license […]
Licensing Agreement for Multiple Pediatric-focused Products between Lupin and MonoSol Rx
Reportedly, Lupin Pharmaceutical Inc.(LPI,US subsidiary of pharma major Lupin Limited) and MonoSol Rx, a specialty pharmaceutical company have entered into a strategic licensing agreement (OCT-2016) wherein Lupin would develop multiple pediatric products utilizing MonoSol Rx’s patented PharmFilm® drug delivery technology. Lupin Limited is an innovation led transnational pharmaceutical company which develops and offers a wide […]
RENOVA Expands Intellectual Property Portfolio For Cardiovascular And Metabolic Disease Treatments
Renova Therapeutics(hereinafter referred as “Renova”) founded in 2009 and headquartered in San Diego, California, a biopharmaceutical company develops gene therapy treatments for congestive heart failure (CHF) and other chronic diseases The Company also provides gene therapies in pre-clinical stage for those who suffer from Type II diabetes. Reportedly, Renova has obtained an exclusive worldwide license […]
Licensing Agreement for Multiple Pediatric-focused Products between Lupin and MonoSol Rx
Reportedly, Lupin Pharmaceutical Inc.(LPI,US subsidiary of pharma major Lupin Limited) and MonoSol Rx, a specialty pharmaceutical company have entered into a strategic licensing agreement (OCT-2016) wherein Lupin would develop multiple pediatric products utilizing MonoSol Rx’s patented PharmFilm® drug delivery technology. Lupin Limited is an innovation led transnational pharmaceutical company which develops and offers a wide […]